Login / Signup

An Update on the Diagnosis and Management of Calcium Crystal Disease.

Rachael Mary FloodJohn StackGeraldine McCarthy
Published in: Current rheumatology reports (2023)
The awaited development of classification criteria is an essential step in the progression of calcium crystal deposition disease clinical research. There have been recent improvements in the accuracy of imaging for the diagnosis of crystal deposition diseases with published definitions of characteristic features. Factors associated with acute flares of disease have been identified and an association with increased cardiovascular risk has been demonstrated. Targeted treatment options for calcium crystal diseases remain elusive. However, there have been advances in understanding the molecular mechanisms of disease revealing potential targets for future drug development. Calcium-crystal deposition diseases are increasing in incidence and prevalence as populations age and continue to associate with a high burden of disability. Despite this, calcium crystal deposition disease remains under-studied with a paucity of evidence-based treatment guidelines.
Keyphrases
  • risk factors
  • randomized controlled trial
  • systematic review
  • drug delivery
  • climate change
  • current status
  • extracorporeal membrane oxygenation
  • fluorescence imaging
  • mechanical ventilation